Inventor
LARSON STEVEN M
US18 patents
⚠️ This page may combine multiple inventors who share the name “LARSON STEVEN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLOAN KETTERING INST CANCER RES
8 patentsUS10548998B2Feb 4, 2020
Multimodal silica-based nanoparticles
SLOAN KETTERING INST CANCER RES19 citations93
US9999694B2Jun 19, 2018
Multimodal silica-based nanoparticles
SLOAN KETTERING INST CANCER RES19 citations93
US10039847B2Aug 7, 2018
Multimodal silica-based nanoparticles
SLOAN KETTERING INST CANCER RES15 citations91
US10548997B2Feb 4, 2020
Fluorescent silica-based nanoparticles
SLOAN KETTERING INST CANCER RES14 citations84
US11419955B2Aug 23, 2022
Multimodal silica-based nanoparticles
SLOAN KETTERING INST CANCER RES5 citations83
US10676476B2Jun 9, 2020
Small-molecule HSP90 inhibitors
SLOAN KETTERING INST CANCER RES3 citations71
US12161734B2Dec 10, 2024
Multimodal silica-based nanoparticles
SLOAN KETTERING INST CANCER RES0 citations61
US11607465B2Mar 21, 2023
Uses of labeled HSP90 inhibitors
SLOAN KETTERING INST CANCER RES1 citations59
MEMORIAL SLOAN KETTERING CANCER CENTER
7 patentsUS10167285B2Jan 1, 2019
Small-molecule HSP90 inhibitors
MEMORIAL SLOAN KETTERING CANCER CENTER6 citations82
US11633502B2Apr 25, 2023
Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations60
US11565005B2Jan 31, 2023
Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER1 citations59
US12582728B2Mar 24, 2026
Theranostic agents for PSMA positive cancers
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations53
US12533428B2Jan 27, 2026
Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations53
US12195554B2Jan 14, 2025
Anti-polysialic acid antibodies and uses thereof
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations48
US10806808B2Oct 20, 2020
Systems and methods for determining optimum patient-specific antibody dose for tumor targeting
MEMORIAL SLOAN KETTERING CANCER CENTER0 citations28
US HEALTH
2 patentsUS4775759AOct 4, 1988
Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US HEALTH46 citations90
US5185142AFeb 9, 1993
Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy
US HEALTH10 citations63